Where it is registered
Each register with its number of medicines and a few of them.
Canada
Health Canada · 8 medicines
- Act-Hib10 MCG / 0.5 ML + 30 MCG / 0.5 ML · Kit, Powder For Solution · Sanofi Vaccines Canada LTD.
- Infanrix Hexa25 LF / 0.5 ML + 25 MCG / 0.5 ML + 10 MCG / 0.5 ML + 10 MCG / 0.5 ML + 8 MCG / 0.5 ML + 25 MCG / 0.5 ML + 40 UNIT / 0.5 ML + 8 UNIT / 0.5 ML + 32 UNIT / 0.5 ML + 10 LF / 0.5 ML + 40 MCG / 0.5 ML · Suspension · Glaxosmithkline INC
- Pentacel15 LF / 0.5 ML + 20 MCG / 0.5 ML + 5 MCG / 0.5 ML + 10 MCG / 0.5 ML + 3 MCG / 0.5 ML + 20 MCG / 0.5 ML + 29 UNIT / 0.5 ML + 7 UNIT / 0.5 ML + 26 UNIT / 0.5 ML + 30 MCG / 0.5 ML + 5 LF / 0.5 ML · Suspension · Sanofi Vaccines Canada LTD.
- Liquid Pedvaxhib7.5 MCG / 0.5 ML + 125 MCG / 0.5 ML · Suspension · Merck Canada INC
All medicines with Haemophilus influenzae type b-prp
Every register, a page at a time. Strengths and packs are on each medicine’s page.
10 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Infanrix HexaCombination | Canada | 25 LF / 0.5 ML + 25 MCG / 0.5 ML + 10 MCG / 0.5 ML + 10 MCG / 0.5 ML + 8 MCG / 0.5 ML + 25 MCG / 0.5 ML + 40 UNIT / 0.5 ML + 8 UNIT / 0.5 ML + 32 UNIT / 0.5 ML + 10 LF / 0.5 ML + 40 MCG / 0.5 ML | Suspension | Marketed | Glaxosmithkline INC |
| Act-HibCombination | Canada | 10 MCG / 0.5 ML + 30 MCG / 0.5 ML | Kit, Powder For Solution | Marketed | Sanofi Vaccines Canada LTD. |
| PentacelCombination | Canada | 15 LF / 0.5 ML + 20 MCG / 0.5 ML + 5 MCG / 0.5 ML + 10 MCG / 0.5 ML + 3 MCG / 0.5 ML + 20 MCG / 0.5 ML + 29 UNIT / 0.5 ML + 7 UNIT / 0.5 ML + 26 UNIT / 0.5 ML + 30 MCG / 0.5 ML + 5 LF / 0.5 ML | Suspension | Marketed | Sanofi Vaccines Canada LTD. |
| Prohibit Inj VaccineCombination | Canada | 23 MCG / 0.5 ML + 25 MCG / 0.5 ML | Liquid | Cancelled | Aventis Pasteur Limited |
| Pedvaxhib Inj PWSCombination | Canada | 15 MCG / VIAL + 250 MCG / VIAL | Powder For Solution | Cancelled | Merck Manufacturing Division, Division of Merck & Co., INC. |
| PediacelCombination | Canada | 15 LF / 0.5 ML + 20 MCG / 0.5 ML + 5 MCG / 0.5 ML + 10 MCG / 0.5 ML + 29 UNIT / 0.5 ML + 7 UNIT / 0.5 ML + 26 UNIT / 0.5 ML + 3 MCG / 0.5 ML + 20 MCG / 0.5 ML + 30 MCG / 0.5 ML + 5 LF / 0.5 ML | Suspension | Cancelled | Sanofi Vaccines Canada LTD. |
| PentacelCombination | Canada | 15 LF / 0.5 ML + 20 MCG / 0.5 ML + 5 MCG / 0.5 ML + 10 MCG / 0.5 ML + 40 UNIT / 0.5 ML + 8 UNIT / 0.5 ML + 32 UNIT / 0.5 ML + 3 MCG / 0.5 ML + 20 MCG / 0.5 ML + 30 MCG / 0.5 ML + 5 LF / 0.5 ML | Liquid, Powder For Solution | Cancelled | Sanofi Vaccines Canada LTD. |
| Liquid PedvaxhibCombination | Canada | 7.5 MCG / 0.5 ML + 125 MCG / 0.5 ML | Suspension | Cancelled | Merck Canada INC |
| Infanrix-Ipv/HibCombination | Canada | 30 UNIT / 0.5 ML + 25 MCG / 0.5 ML + 10 MCG / 0.5 ML + 40 UNIT / 0.5 ML + 8 UNIT / 0.5 ML + 32 UNIT / 0.5 ML + 8 MCG / 0.5 ML + 25 MCG / 0.5 ML + 40 UNIT / 0.5 ML | Suspension | Marketed | Glaxosmithkline INC |
| Hiberix | Canada | 10 MCG / 0.5 ML | Powder For Solution | Cancelled | Glaxosmithkline INC |
At a glance
- Registers
- 1
- Medicines
- 8
- Companies
- 5